915030-48-7 Usage
Derivative of acetic acid
2-(3,4-difluorophenyl)-2,2-difluoroacetic acid is derived from acetic acid, which means it is structurally similar to acetic acid and contains a carboxyl group (-COOH).
Fluorine atoms on the phenyl ring
Two fluorine atoms are attached to the phenyl ring in the compound, which influences its chemical properties and reactivity.
Pharmaceutical industry use
The compound is predominantly used as an intermediate in the synthesis of various drugs, making it an important building block in the development of new pharmaceuticals.
Therapeutic properties
2-(3,4-difluorophenyl)-2,2-difluoroacetic acid possesses potential therapeutic properties and is being studied for its pharmacological activity in the treatment of various diseases.
Organic chemical synthesis
The compound is also employed as a building block in the preparation of fluorinated organic compounds, which have a wide range of applications in the chemical industry.
Interest in drug development and medicinal chemistry
Due to its unique chemical structure and properties, the compound has garnered interest in both academic and industrial sectors for its potential applications in these fields.
Check Digit Verification of cas no
The CAS Registry Mumber 915030-48-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,5,0,3 and 0 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 915030-48:
(8*9)+(7*1)+(6*5)+(5*0)+(4*3)+(3*0)+(2*4)+(1*8)=137
137 % 10 = 7
So 915030-48-7 is a valid CAS Registry Number.
915030-48-7Relevant academic research and scientific papers
2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1)
-
Page/Page column 53, (2008/06/13)
The use of a compound of formula (I): for the manufacture of a medicament for the treatment of conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1, also known as TRPV1).
